Document ID: chunk:federal_register_of_legislation:F2025C00083:reg:32a:p2
Version: federal_register_of_legislation:F2025C00083
Segment Type: reg
Provision Reference: reg 32A (pt 2/5)
Character Range: 81456–84463

the benefit, or of another Pharmaceutical benefit that is Schedule equivalent to the benefit, was made upon an increased maximum quantity prescription directing the supply of:
 (i) the benefit; or
 (ii) another Pharmaceutical benefit that is Schedule equivalent to the benefit; and
 (c) both the supplies mentioned in paragraphs (a) and (b) are of the increased maximum quantity of the relevant Pharmaceutical benefit.

Part 5A—Pharmaceutical Reimbursement

       Definitions:
  In this Part:
member means an Eligible Person eligible for payment of a pharmaceutical reimbursement.
veteran means a person eligible under the Repatriation Pharmaceutical Benefits Scheme for the payment known as the "pharmaceutical reimbursement".

       33
  The Commission may, subject to this Part, accept financial responsibility for the pharmaceutical reimbursement.
Note: if the Commission accepts financial responsibility for a cost in relation to the provision of a Pharmaceutical benefit to an Eligible Person, the Commonwealth pays that cost.

       34
  The pharmaceutical reimbursement is a financial amount that would compensate an Eligible Person for out‑of‑pocket expenses:
 (a) that the person incurred in respect of a Pharmaceutical benefit provided under this Scheme; or
 (b) that the person incurred in respect of a Pharmaceutical benefit provided other than under this Scheme but provided on or from a date when the Commission accepted liability to provide treatment to the person under the Act.
Note 1: under the Acts Interpretation Act 1901 words in the singular number (e.g. Pharmaceutical benefit) include the plural and words in the plural number include the singular.
Note 2: paragraph (b) covers what are known as "MEPIs" (Medical Expenses Privately Incurred).  Under the Act eligibility for treatment can be backdated for 3 months before a claim for pension is received and treatment costs incurred in that period e.g. co‑payments for Pharmaceutical benefits, may be met by the Department.

       35
  The amount of pharmaceutical reimbursement is worked out under 39.

       36  Eligibility for Payment of Pharmaceutical Reimbursement
 (1) To be eligible for payment of the pharmaceutical reimbursement an Eligible Person must:
 (a) have rendered warlike service; and
 (b) be entitled to compensation under section 68 or section 75 of the Act or suffer from a SRCA disability.
          Note (1): warlike service is defined in subsection 6(1) of the Act.
Note (2): section 68 is about compensation for a service injury or disease that has resulted in an impairment likely to continue indefinitely and section 75 (interim compensation) is about compensation under section 68 or section 71 where an impairment has not stabilised.
Note (3): section 69 of the Act generally requires the degree of impairment to be at least 10 impairment points before compensation is payable under s.68 but in certain cases it can be 5.

       37  Calculation of annual value of pharmaceutical allowance component